CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Alendronate sodium / cholecalciferol

Last Updated: December 18, 2008
Result type: Reports
Project Number: S0153
Product Line: Common Drug Review

Generic Name: Alendronate sodium / cholecalciferol

Brand Name: Fosavance 70/5600

Manufacturer: Merck Frosst Canda Ltd.

Indications: Osteoporosis

Submission Type: New

Project Status: Complete

Date Recommendation Issued: June 17, 2009

Recommendation Type: List in a similar manner to other drugs in class